News | August 06, 2023
Tatva Chintan Pharma Chem posts Q1 FY24 consolidated PAT at Rs. 9.50 Cr
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
Chintan Shivir has provided a platform to hold discussions with higher officials and experts, which will help in evolving better practices of premier health institutions like AIIMS
Marks the World Head & Neck Cancer Day at the OCTF Conference
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
Subscribe To Our Newsletter & Stay Updated
